Quarterly ResultMay 15, 2026, 04:51 PM
Lunai Bioworks Narrows 9-Month Net Loss to $(1.55M); Going Concern Warning
AI Summary
Lunai Bioworks Inc. reported a significant reduction in its net loss for the nine months ended March 31, 2026, to $(1.55) million, a substantial improvement from $(51.28) million in the prior year. This improvement was partly due to the absence of a large goodwill impairment charge and a $12.02 million gain from the bankruptcy of a subsidiary. Despite these improvements, the company issued a going concern warning due to recurring losses and dependence on additional financing. The company also began recognizing service revenue of $20,942 during the period.
Key Highlights
- Net loss for nine months ended March 31, 2026, improved to $(1.55) million from $(51.28) million YoY.
- Basic loss per share improved to $(0.07) from $(3.18) for the nine-month period.
- Company issued a going concern warning due to recurring losses and financing dependence.
- Recorded a $12.02 million gain from the bankruptcy of Gedi Cube B.V. subsidiary.
- Operating expenses decreased to $6.58 million from $62.05 million YoY, mainly due to no goodwill impairment.
- Generated first service revenue of $20,942 for the nine months ended March 31, 2026.
- Cash balance increased to $3.16 million as of March 31, 2026, from $92,700 at June 30, 2025.
- Total liabilities decreased to $19.41 million from $29.58 million YoY.
Price Impact
More from LNAI